The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patie...

Full description

Bibliographic Details
Main Authors: Alia Saberi, Amirreza Ghayegran, Mojtaba Abbasalizade, Zeinab Ehtiatkar, Samaneh Ghorbani Shirkouhi, Parisa Shahshahani, Hamidreza Hatamian, Sasan Andalib
Format: Article
Language:English
Published: Guilan University of Medical Sciences 2021-07-01
Series:Caspian Journal of Neurological Sciences
Subjects:
tissue plasminogen activator
stroke
thrombolytic therapy
Online Access:http://cjns.gums.ac.ir/article-1-439-en.html

Internet

http://cjns.gums.ac.ir/article-1-439-en.html

Similar Items